Article
Volatilomic response to targeted cancer therapy in vitro
3 Jun 2025
Abstract excerpt
Clinical advancement of novel therapeutics is often hindered by variable patient responses. Therefore, clinically translatable biomarkers of response are urgently required to facilitate precision medicine trials. Endogenous volatile organic compounds (VOCs) can be non-invasively detected in exhaled breath and biofluids and have shown great potential for early cancer detection. Since emerging evidence suggests...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
